PCV28 COST-UTILITY ANALYSIS FOR STATINS IN MEXICO
نویسندگان
چکیده
منابع مشابه
neonatal screening: cost-utility analysis for galactosemia
background: galactosemia is a congenital metabolic disorder that can damage the health of a newborn. screening is an important step to prevent and treat this condition. due to increasing health care costs and limited financial resources of health systems, the most suitable economic analysis tool should be applied. the aim of this study was to analyze the cost-utility of neonatal screening progr...
متن کاملUtility Estimation of Health Status of Cancer Patients by Mapping for Cost-Utility Analysis
Background: It is important to obtain accurate information about the preferences of people for measuring quality-adjusted life years (QALYs), because it is necessary for cost-utility analysis. In this regard, mapping is a method to access this information. Therefore, the purpose of this study was to map Functional Assessment of Cancer Therapy – General (FACT-G) onto Short Form Six Dimension (SF...
متن کاملTeriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis in Iran
Background: Teriparatide is a new agent serves as a treatment of choice for severe post-menopausal osteoporotic patients who are at a high risk of fracture or have failed or been intolerant of previous osteoporosis therapy. The objective of this study is estimating the cost-utility of Teriparatide compared with no treatment from health system perspective in Iran. Method: A microsimulation...
متن کاملA cost–utility analysis
Neurology S. Claiborne Johnston, Daryl R. Gress and James G. Kahn Which unruptured cerebral aneurysms should be treated?: A cost–utility analysis This information is current as of January 25, 2006 http://www.neurology.org/cgi/content/full/52/9/1806 located on the World Wide Web at: The online version of this article, along with updated information and services, is Print ISSN: 0028-3878. Online ...
متن کاملTeriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis in Iran
Background: Teriparatide is a new agent serves as a treatment of choice for severe post-menopausal osteoporotic patients who are at a high risk of fracture or have failed or been intolerant of previous osteoporosis therapy. The objective of this study is estimating the cost-utility of Teriparatide compared with no treatment from health system perspective in Iran. Method: A microsimulation...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2005
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)62669-1